Physician's Weekly Combination Agent Approved for Type 2 Diabetes

Combination Agent Approved for Type 2 Diabetes

Posted By Physicians Weekly On May 1, 2012 @ 5:45 am In Articles,Diabetes,Endocrinology,News Brief,Primary Care | No Comments

The FDA has approved a linagliptin/metformin hydrochloride combination tablet (Jentadueto, Boehringer Ingelheim and Eli Lilly) for use in people with type 2 diabetes. Taken twice-daily, the drug is indicated for use along with diet and exercise to improve glycemic control.

Source: Boehringer Ingelheim ^[1].

Article printed from Physician's Weekly: http://www.physiciansweekly.com

URL to article: http://www.physiciansweekly.com/combination-agent-approved-for-type-2-diabetes/

URLs in this post:

[1] Boehringer Ingelheim: http://www.boehringer-ingelheim.com/news/news_releases/press_releases/2012/31_january_2012_diabetes.html

Click here to print.